PURE Bioscience
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. PURE Bioscience's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $1,963,000. The net income raised on -$3,350,000 and profit margin reached -171%. Total operating expenses were $4,283,000.

Profit Margin

PURE Bioscience, Inc. (OTC:PURE): Profit margin
2015 729K -7.61M -1044.44%
2016 1.28M -21.68M -1682.31%
2017 1.83M -6.51M -355.98%
2018 1.77M -7.47M -421.36%
2019 1.90M -6.56M -343.69%
2020 6.91M -6K -0.09%
2021 3.92M -2.31M -59.05%
2022 1.85M -3.49M -188.72%
2023 1.87M -3.96M -211.03%
2024 1.96M -3.35M -170.66%

PURE Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
1.96M1.87M1.85M3.92M6.91M1.90M1.77M1.83M1.28M729K
Cost of revenue
811K906K853K1.85M2.89M728K763K760K441K285K
Gross profit
1.15M971K1M2.07M4.02M1.18M1.01M1.07M848K444K
Operating exp.
Research and development
302K297K319K339K322K354K459K779K927K790K
Selling and marketing
0000000000
Total operating expenses
4.28M4.59M4.42M4.38M4.01M6.77M8.05M7.07M7.90M8.08M
Operating income
-3.13M-3.94M-3.42M-2.31M9K-5.58M-7.04M-6.00M247K-7.64M
Other income (expenses), net
-219K-18K-66K-8K0-965K-400K-255K-14.61M13K
Income before tax
-3.35M-3.96M-3.49M-2.31M4K-6.55M-7.44M-6.26M-14.37M-7.62M
Income tax expense
010K6K010K7K33K255K7.31M-13K
Net income
-3.35M-3.96M-3.49M-2.31M-6K-6.56M-7.47M-6.51M-21.68M-7.61M
Earnings per share
Basic EPS
-0.02-0.03-0.03-0.02-0.00-0.09-0.11-0.1-0.38-0.19
Diluted EPS
-0.02-0.03-0.03-0.02-0.00-0.09-0.11-0.1-0.38-0.19
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source